Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
The trial also demonstrated significant improvements across multiple secondary endpoints
Marks significant milestone for breakthrough biologic to treat rare blood cancers
Huwel’s diagnostic solutions leverage open RT-PCR system
The pioneering monoclonal antibody is for Essential Thrombocythemia (ET) and Polycythemia Vera (PV), rare chronic blood cancers with limited treatment options
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs)
Comprehensive clinical development programs being initiated for each investigational candidate
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Subscribe To Our Newsletter & Stay Updated
